JANX:NASDAQ, Janux Therapeutics, Inc.

JANX stock overview

Janux Therapeutics, Inc. (JANX:NASDAQ) closed at $10.08 on November 20, 2026, down 2.04% on the day. The stock trades 71.5% below its 52-week high of $35.34 and 0.3% above its 52-week low of $10.05. Over the past year, it lost 68.0%. Janux Therapeutics, Inc. is part of the Health Care sector.

Key figures

Price
$10.08
Day change
-2.04%
Volume
1,114,707
Average volume
952,264
Market cap
616M+
52-week range
$10.05 – $35.34
50-day average
$16.10
200-day average
$15.30

Price action over the past year

In 252 trading sessions since November 20, 2025, JANX closed higher on 123 days (49%). Its best day was January 22, 2026 (+14.09%) and its worst was December 2, 2025 (-53.34%). The stock moved 10% or more in a single session 5 times.

Recent signals

JANX news

About Janux Therapeutics, Inc.

Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer.

Similar stocks

Find more stocks like JANX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.